Turing Biosystems

📍 London, United Kingdom👥 9 employees💰 Last funded Nov 2022
Biotechnology Research🌐 turing.bio
Website LinkedIn
Turing Biosystems tackles high failure rates and adverse immune responses to immunotherapy and cell & gene therapy. Our software platform is based on a new kind of interpretable AI that works through automated reasoning. Built on specialized chips, it can integrate any and all modes of clinical/biological data, analyse patient responses to therapies, and design better healthcare interventions. Were here to help both clinicians and biopharma get the right treatments to the right patients at the right time.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Germany
1
United Kingdom
1
Frequently asked questions
Who invested in Turing Biosystems?
Turing Biosystems has 2 investors on record on gritt.io.
When did Turing Biosystems last raise funding?
The most recent investment in Turing Biosystems recorded on gritt.io was in November 2022.
What industry is Turing Biosystems in?
Turing Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Turing Biosystems based?
Turing Biosystems is headquartered in London, United Kingdom.